Variability of the urological clinical practice in prostate cancer in Spain

被引:7
作者
Nunez, C. [1 ]
Angulo, J. [2 ]
Sanchez-Chapado, M. [3 ]
Alonso, S. [4 ]
Portillo, J. A. [5 ]
Villavicencio, H. [6 ]
机构
[1] MD Anderson Int, Madrid, Spain
[2] Univ Europea Madrid, Hosp Univ Getafe, Madrid, Spain
[3] Univ Alcala, Hosp Univ Principe Asturias, Madrid, Spain
[4] Abbott Labs SA, Dept Med, Madrid, Spain
[5] Hosp Univ Marques de Valdecilla, Santander, Spain
[6] Fundacio Puigvert, Barcelona, Spain
来源
ACTAS UROLOGICAS ESPANOLAS | 2012年 / 36卷 / 06期
关键词
Prostate cancer; Diagnosis; Treatment; Clinical variability; Patient; Medical professional;
D O I
10.1016/j.acuro.2012.02.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Study the opinion of the Spanish urologists regarding the main points in the diagnosis, prevention, quality of life and treatment of prostate cancer. Material and methods: An anonymous questionnaire was administered to 290 specialists who represented the urological professional group involved in the management of prostate cancer in Spain. The following were considered in their definition: grade of professional experience, work setting, contractual relation with patient and academic character of the center. The statistical analysis was based on the study of relative frequencies for qualitative variables. The results were interpreted in 2009-10 and the final report of them was done in 2011. Results: Response rate collected and correctly transcribed from the forms was 96.9% (n = 281). This accounts for 10-15% of the national group. Median age was 47.7 (29-69) years and 92% were men. Mean years of professional experience were 19.1 (1-43). Responses collected regarding 153 questions were analyzed. These dealt with: a) How the diagnosis of the disease was carried out in the setting of the surveyed; b) The opinions given on the disease prevention; c) Treatment of the localized treatment; d) Treatment of the advanced disease; and e) The definition of the fields of interest for the professional. Conclusion: This survey showed important variability in some points of clinical practice in regards to the recommendations of the experts. It also shows the principal concerns of the professional, defines opportunities for training improvements and detects needs in the national urological group. (C) 2012 AEU. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:333 / 339
页数:7
相关论文
共 17 条
[1]  
Alcaraz A, 2012, ACTAS UROL ESP, V36, P367, DOI [10.1016/j.acuro.2011.10.010, 10.1016/j.acuroe.2011.10.001]
[2]  
[Anonymous], 2008, GUIA PRACT CLIN TRAT
[3]  
Cabrera P, 2009, REV UROL, V10, P217
[4]  
Cairns P, 2001, CLIN CANCER RES, V7, P2727
[5]   Consensus on the Clinical Impact of the New Scientific Evidence Available on Benign Prostatic Hyperplasia [J].
Cozar-Olmo, J. M. ;
Hernandez-Fenandez, C. ;
Minana-Lopez, B. ;
Amon-Sesmero, J. H. ;
Montlleo-Gonzalez, M. ;
Rodriguez-Antolin, A. ;
Caballero-Martinez, F. .
ACTAS UROLOGICAS ESPANOLAS, 2012, 36 (05) :265-275
[6]  
Fernández-Serra A, 2011, ACTAS UROL ESP, V35, P420, DOI [10.1016/j.acuro.2010.11.019, 10.1016/j.acuroe.2010.11.001]
[7]  
Gómez-Veiga F, 2011, ACTAS UROL ESP, V35, P315, DOI [10.1016/j.acuro.2011.02.001, 10.1016/j.acuroe.2011.02.001]
[8]  
GOODMAN LA, 1961, ANN MATH STAT, V32, DOI [DOI 10.1214/AOMS/1177705148, 10.1214/aoms/1177705148]
[9]  
Heidenreich A, 2010, CLIN GUIDELINES PROS
[10]  
Heindenreich A, 2011, ACTAS UROL ESP, V35, P501